Literature DB >> 32002399

Concomitant Orbital Tumours: Small Lymphocytic Lymphoma Involving the Lacrimal Gland of a Patient with Clinical Diagnoses of Muir-Torre Syndrome and Extensive Sebaceous Gland Carcinoma of the Ipsilateral Eyelid.

Konstantinos Kopsidas1, Rebecca Ford1, Ibrar Ahmed2, Sarah E Coupland2.   

Abstract

BACKGROUND/AIMS: We present a case of 2 concomitant tumours, i.e., a sebaceous carcinoma (SC) and a small lymphocytic lymphoma (SLL), in the lacrimal gland of a patient with Muir-Torre syndrome.
METHODS: Clinical history, orbital examination, diagnostic biopsy, excisional biopsy, and histopathologic analysis were utilized.
RESULTS: An 89-year-old female presented to the eye casualty with corneal ulcer, anterior uveitis, proptosis, and restricted ocular motility. She has a clinical history of breast cancer, colon carcinoma, and SC of the eyelid, which had been resected completely 2 years before. Clinical examination, imaging, and diagnostic biopsy confirmed orbital SC recurrence. Exenteration and subsequent histopathologic analysis of the specimen revealed lymphocytic infiltrates consistent with SLL within the lacrimal gland.
CONCLUSION: We report for the first time a case of a patient with Muir-Torre syndrome who developed an orbital recurrent SC with an incidental finding of a lacrimal gland B non-Hodgkin lymphoma consistent with SLL. Clinicians should be aware of the possibility of this coexistence of multiple cancer types in patients with sebaceous carcinoma and Muir-Torre syndrome.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Collision tumour; Eyelid tumour; Muir-Torre syndrome; Orbital tumour; Sebaceous carcinoma; Small lymphocytic lymphoma

Year:  2019        PMID: 32002399      PMCID: PMC6984142          DOI: 10.1159/000500161

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  8 in total

Review 1.  Sebaceous carcinoma of the ocular region: a review.

Authors:  Jerry A Shields; Hakan Demirci; Brian P Marr; Ralph C Eagle; Carol L Shields
Journal:  Surv Ophthalmol       Date:  2005 Mar-Apr       Impact factor: 6.048

Review 2.  Muir-Torre syndrome.

Authors:  Giovanni Ponti; Maurizio Ponz de Leon
Journal:  Lancet Oncol       Date:  2005-12       Impact factor: 41.316

3.  Dual role of inactivating Lef1 mutations in epidermis: tumor promotion and specification of tumor type.

Authors:  Catherin Niemann; David M Owens; Peter Schettina; Fiona M Watt
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

4.  Sebaceous carcinoma in the clinical setting of non-Hodgkin lymphoma: the Mayo Clinic experience.

Authors:  Timothy W Chang; Amy L Weaver; Jerry D Brewer
Journal:  Int J Dermatol       Date:  2013-05-15       Impact factor: 2.736

5.  Sebaceous gland carcinoma. Review of 40 cases.

Authors:  M T Doxanas; W R Green
Journal:  Arch Ophthalmol       Date:  1984-02

6.  Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.

Authors:  Ruchi Mittal; Iguaracyra Araujo; Gabriela Czanner; Sarah E Coupland
Journal:  Acta Ophthalmol       Date:  2016-02-04       Impact factor: 3.761

7.  Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function?

Authors:  K Hemminki; Y Jiang; G Steineck
Journal:  Eur J Cancer       Date:  2003-01       Impact factor: 9.162

8.  High lymphoid enhancer-binding factor-1 expression is associated with disease progression and poor prognosis in chronic lymphocytic leukemia.

Authors:  Felix Erdfelder; Magdalena Hertweck; Alexandra Filipovich; Sabrina Uhrmacher; Karl-Anton Kreuzer
Journal:  Hematol Rep       Date:  2010-05-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.